Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Variants in the CCDC47 gene are linked to trichohepatoneurodevelopmental syndrome.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Mutations in the KRT85 gene cause hair and nail problems.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

TAp63 and NRF2 work together to manage oxidative stress, preventing premature aging and aiding skin functions.

A specific gene mutation causes a rare hair loss condition in a Chinese patient.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

The Fas/FasL pathway may play a role in alopecia areata.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

The IRF2BP2 gene affects sheep fleece quality by influencing fiber traits.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.